Medicine and Dentistry
Mycosis fungoides
100%
Diseases
83%
Psoriasis
64%
Melanoma
49%
B Cell
42%
Diagnosis
35%
Cutaneous T Cell Lymphoma
32%
Neoplasm
31%
Dermatology
30%
Keratinocyte
28%
Prevalence
26%
Quality of Life
26%
Cutaneous Lymphoma
24%
Metastatic Melanoma
24%
Retrospective Study
24%
Skin Cancer
23%
Skin Carcinoma
21%
Phototherapy
21%
Epithelioma
21%
Proteochondroitin Sulfate
21%
Hypoxia Inducible Factor 1
21%
Therapy Resistance
21%
Tumour Heterogeneity
21%
Sorafenib
21%
DNA Repair
21%
Cancer Treatment
21%
Vasculotropin
21%
Cushing Disease
21%
Carney Complex
21%
Cancer Therapy
21%
Leg Ulcer
21%
T-Cell Lymphoma
21%
RNA Sequence
21%
Hepatocellular Carcinoma
21%
Clusterin
21%
Neutrophil
21%
Outpatient
21%
Platelet
21%
Cross Sectional Study
21%
Actinic Keratosis
21%
Apremilast
21%
Skin Biopsy
21%
Soft Tissue Infection
21%
Notch Signaling
21%
Pancreatitis
21%
Fibrinogen
21%
Biological Product
21%
Mammalian Cell
21%
Lymphocyte
21%
Trametinib
21%
Polyarthritis
21%
Lupus Erythematosus Panniculitis
21%
Interleukin 23p19
21%
Immunity
21%
Interleukin 23 Antibody
21%
T Cell
17%
In Vitro
17%
Carotid Artery Stenosis
17%
Biopsy Technique
16%
Cancer
16%
Messenger RNA
15%
Follicle
14%
Skin Defect
14%
Pancreatic Duct
14%
Apoplexy
12%
Interleukin 23
12%
Internal Carotid Artery
12%
Psoriasis Area and Severity Index
12%
Erythroderma
11%
Chronic Pancreatitis
10%
Gram-Negative Bacteria
10%
Gram-Positive Bacteria
10%
Malignant Neoplasm
10%
PUVA
10%
Squamous Cell Carcinoma
10%
Disease Course
8%
Life Expectancy
8%
Adverse Event
8%
Rank Sum Test
8%
Thromboembolism
8%
Dermatology Life Quality Index
8%
Angiogenesis
8%
Allogeneic Stem Cell Transplantation
7%
Photochemotherapy
7%
Methoxsalen
7%
Systemic Therapy
7%
Consultation
7%
Cell Line
7%
Recurrent Disease
7%
Inflammatory Infiltrate
7%
Oncogene
7%
Cancer Cell
7%
B Lymphocyte Receptor
7%
Upregulation
7%
Basophil Cell
7%
Cell Membrane
7%
Endoscopic Retrograde Cholangiopancreatography
7%
Antimicrobial Agent
7%
Aneuploidy
7%
HaCaT
7%
Immunology and Microbiology
Immunoglobulin E
85%
Allergen
73%
Birch
42%
Molecular Weight
28%
ELISA
26%
Squamous Cell
24%
Talimogene Laherparepvec
21%
Permeability Barrier
21%
TNF Inhibitor
21%
Adalimumab
21%
Kidney Transplantation
21%
Cell Invasion
21%
Single-Chain Variable Fragment
21%
Notch
21%
Heat Shock
21%
Hypersensitive Response
21%
Holocephali
21%
Nicotiana benthamiana
21%
Extract
21%
Mastocytosis
21%
Allergenicity
21%
Sorafenib
21%
Fibrinogen
21%
Proteome Analysis
21%
CD44
21%
Lactobacillus buchneri
21%
Antigen Presentation
21%
Psoriatic Arthritis
21%
Western Blot
19%
Basophil
19%
Infliximab
17%
Sensitization
16%
Cross-Reactive Carbohydrate Determinants
14%
Biopanning
12%
Mucosa
10%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
10%
Penicillin
10%
Tissue Water
10%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
10%
Coagulase Negative Staphylococcus
10%
Gel Mobility Shift Assay
10%
Genetic Transcription
10%
EC50
10%
Immune Response
9%
Somatic Cell
7%
Pistachio
7%
Electron Beam
7%
Gamma Delta T-Cell
7%
Chondroitin Sulfate Proteoglycan
7%
Fluorescence Activated Cell Sorting
7%
Melanoma Cell Line
7%
MAPK Signaling
7%
Nivolumab
7%
Myasthenia gravis
7%
Artemisia vulgaris
7%
B-Cell Receptor
7%
Oncogene
7%
Immunoglobulin E Antibody
7%
Mediator
7%
Cancer Staging
7%
Plant-Based Food
7%
Anaphylaxis
7%
Basophil Granulocyte
5%
Cross-Reactivity
5%
Comorbidity
5%
Escherichia coli
5%
Histamine Release
5%
Cause Specific Survival
5%
Whole Cell
5%
Stem Cell
5%
Cell Marker
5%
Pollen Allergy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mycosis fungoides
42%
Psoriasis
42%
Biological Product
32%
Metastatic Melanoma
29%
Psoriatic Arthritis
25%
Trametinib
24%
Dabrafenib
24%
Disease
23%
Skin Cancer
21%
Talimogene Laherparepvec
21%
Progression Free Survival
21%
Apremilast
21%
Epithelium Tumor
21%
Aminolevulinic Acid
21%
Hemosiderin
21%
Psoriasis Vulgaris
21%
Tumor Necrosis Factor Inhibitor
21%
Retrospective Study
21%
Chondroitin Sulfate
21%
Interleukin 23 Antibody
21%
Interleukin 23p19
21%
Secukinumab
21%
Ustekinumab
21%
Interleukin 17 Antibody
21%
Ixekizumab
21%
EC50
21%
Melanoma
21%
Cyclorphan
21%
Combination Therapy
21%
Sorafenib
21%
Gene Delivery
21%
Skin Carcinoma
21%
Lactobacillus buchneri
21%
Infliximab
17%
Carotid Artery Obstruction
17%
Overall Survival
17%
Soft Tissue Infection
14%
Etanercept
14%
Adalimumab
14%
Nivolumab
14%
Heat Shock Protein
12%
Interleukin 23
12%
Survival Rate
12%
Lactate Dehydrogenase
8%
Lung Metastasis
8%
Cause Specific Survival
8%
Meticillin
7%
Cefalexin
7%
Penicillin G
7%
Aminopenicillin
7%
Beta Lactam Antibiotic
7%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
7%
Coagulase Negative Staphylococcus
7%
Clindamycin
7%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
7%
Avelumab
7%
Atezolizumab
7%
Contact Dermatitis
6%
Life Expectancy
5%
Basal Cell Carcinoma
5%
Squamous Cell Carcinoma
5%
Malignant Neoplasm
5%
Cemiplimab
5%